Michael Whitehead
AeroLeads people directory · profile

Michael Whitehead Email & Phone Number

BD at RNAvate at RNAvate
Location: London Area, United Kingdom 11 work roles 3 schools
LinkedIn matched
✓ Verified Jul 2026 3 data sources Profile completeness 100%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
BD at RNAvate
Location
London Area, United Kingdom
Company size

Who is Michael Whitehead? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Michael Whitehead is listed as BD at RNAvate at RNAvate, a with 8 employees, based in London Area, United Kingdom. AeroLeads shows a matched LinkedIn profile for Michael Whitehead.

Michael Whitehead previously worked as Postdoctoral Research Fellow at Ucl Institute Of Ophthalmology and Scientist/Advisor at Cellestial Health. Michael Whitehead holds Doctor Of Philosophy - Phd, Clinical Neuroscience - Advanced Therapeutics from University Of Cambridge.

Company email context

Email format at RNAvate

This section adds company-level context without repeating Michael Whitehead's masked contact details.

RNAvate

Review company-level records connected to Michael Whitehead before choosing the right outreach path.

Profile bio

About Michael Whitehead

Currently Business Development Manager at RNAvate.Previously Research Associate at UCL, PhD at Uni of Cambridge, MPhil at Uni of Cambridge.

Listed skills include Communication, Team Leadership, Presentations, Problem Solving, and 18 others.

Current workplace

Michael Whitehead's current company

Company context helps verify the profile and gives searchers a useful next step.

RNAvate
Rnavate
BD at RNAvate
global unmet medical need is what fuels each of the Cambridges.
Employees
8
AeroLeads page
11 roles

Michael Whitehead work experience

A career timeline built from the work history available for this profile.

Bd At Rnavate

Current

Cambridge, England, United Kingdom

Business development at RNAvate, an RNA therapeutics company.

Oct 2024 - Present

Postdoctoral Research Fellow

• Project funded by Moorfields Eye Charity. Aim to develop new iPSC models of retinal ganglion cell degeneration caused by mutations affecting mitochondrial genes with the aim of developing new gene therapies• Working under the supervision of Professor Mike Cheetham, Professor Patrick Yu Wai Man and Dr Jennifer Sun• Presented work at international eye conference, ARVO 2023

Oct 2021 - Oct 2024

Scientist/Advisor

Cellestial Health

Cambridge, England, United Kingdom

• Worked in collaboration with Dr. Natalie Hastings (University of Cambridge Wellcome Trust Stem Cell Institute) who is developing a new treatment for a neurological disease• Designed AAV-based vector for modulating activity of gene-of-interest; proved successful at in vitro testing phase

Jun 2020 - Oct 2021

Phd Student

Cambridge, England, United Kingdom

• This Doctoral Training Programme was supported by the Medical Research Council to pursue a 3.5-year PhD focussed on the development of gene therapy treatments for eye diseases• Lead author of three successful grant applications to support independently ideated and funded research programmes to understand the interaction between gene therapy vectors and the humoral immune system, and develop clinically-translatable solutions to this problem• Beneficiary of the Sackler Scholarship… Show more • This Doctoral Training Programme was supported by the Medical Research Council to pursue a 3.5-year PhD focussed on the development of gene therapy treatments for eye diseases• Lead author of three successful grant applications to support independently ideated and funded research programmes to understand the interaction between gene therapy vectors and the humoral immune system, and develop clinically-translatable solutions to this problem• Beneficiary of the Sackler Scholarship Programme which provides additional financial support for the duration of the PhD• Winner of the Cambridge Society for the Application of Research Award 2021• Nominated for the Milo Keynes Thesis Prize 2021• Awarded ARVO Abstract of Distinction 2020 & 2021 Show less

Oct 2017 - Oct 2021

Co-Founder

Celerx

Cambridge, United Kingdom

• Led the creation of a start-up biotechnology project that developed an enzymatic therapy for coeliac disease• Established collaboration with the Soilleux Lab at the University of Cambridge’s Division of Cellular and Molecular Pathology; project funded by BBSRC and Coeliac UK• Authored a successful grant application to Addenbrookes Charitable Trust to provide additional funding for the preclinical research programme• Winner of the ‘£1K’ and finalist of the ‘£5K’ Cambridge… Show more • Led the creation of a start-up biotechnology project that developed an enzymatic therapy for coeliac disease• Established collaboration with the Soilleux Lab at the University of Cambridge’s Division of Cellular and Molecular Pathology; project funded by BBSRC and Coeliac UK• Authored a successful grant application to Addenbrookes Charitable Trust to provide additional funding for the preclinical research programme• Winner of the ‘£1K’ and finalist of the ‘£5K’ Cambridge University Entrepreneurs Business Plan Competition 2017• Accepted onto the University of Cambridge Judge Business School’s ‘Accelerate Cambridge’ venture creation accelerator programme Show less

Jan 2017 - Oct 2019

Chief Financial Officer

Cambridge, United Kingdom

• Successfully liaised and negotiated with Blue Chips and SMEs to secure £15,000 in sponsorship deals for the society• Responsible for the management and financial reporting of a £40,000 bank account• Took a lead role in organising ‘IP Workshops’ and ‘IP Clinics’ for society members – reached maximum capacity for both events and had positive feedback from participating institutions

Oct 2016 - Oct 2017

Business Analyst Intern

Cambridge, United Kingdom

• Tasked with analysing the commercial opportunity for a novel pharmaceutical compound targeting a neurological disorder• Performed in-depth financial analysis (discounted cash flow analysis, real options valuation, pharmacoeconomic modelling, Microsoft Excel Visual Basic Editor MACRO Coding) in order to synthesise final recommendations to the company

May 2017 - Jun 2017

External Consultant

Cambridge, United Kingdom

• Team member on a three-month consultancy project for a biotechnology engineering consultancy – used data collection and analysis tools to solve the client’s problem, and scored 78% (Distinction) in the assessed presentation

Jan 2017 - May 2017

Undergraduate Researcher

Bristol, United Kingdom

• I undertook a four-month research project during my undergraduate studies. Working under the supervision of Dr. Wa'el Kafienah and Dr Daryll Hill, I studied the mechanisms of the adherence of Staphylococcus aureus (Sa) to mesenchymal stem cells (MSCs) during osteomyelitis infections

Sep 2014 - Mar 2015

Business Analyst

Redleaf Womens Hospital

Shanghai, China

• I worked at Redleaf International Women's Hospital (Shanghai, China) for two months in the summer of 2014. Working under the supervision of the Chief Operations Officer, I conducted market research and analysed hospital management literature

Jun 2014 - Sep 2014
3 education records

Michael Whitehead education

Doctor Of Philosophy - Phd, Clinical Neuroscience - Advanced Therapeutics

• Awarded a £120,000 research grant by the Medical Research Council in 2017 to pursue a 3.5-year PhD focussed on the development of gene.

Master Of Philosophy - Mphil, Bioscience Enterprise, Pass (74% Mean Score)

• Developed an in-depth understanding of (i) the drug discovery and clinical development process, (ii) market access and real world.

Bachelor Of Science (Bs), Cellular And Molecular Medicine, 1St

• Developed an understanding of key biomedical and biochemical concepts, including pathology, recombinant DNA technology, and cell.

FAQ

Frequently asked questions about Michael Whitehead

Quick answers generated from the profile data available on this page.

What company does Michael Whitehead work for?

Michael Whitehead works for RNAvate.

What is Michael Whitehead's role at RNAvate?

Michael Whitehead is listed as BD at RNAvate at RNAvate.

Where is Michael Whitehead based?

Michael Whitehead is based in London Area, United Kingdom while working with RNAvate.

What companies has Michael Whitehead worked for?

Michael Whitehead has worked for Rnavate, Ucl Institute Of Ophthalmology, Cellestial Health, University Of Cambridge, and Celerx.

How can I contact Michael Whitehead?

You can use AeroLeads to view verified contact signals for Michael Whitehead at RNAvate, including work email, phone, and LinkedIn data when available.

What schools did Michael Whitehead attend?

Michael Whitehead holds Doctor Of Philosophy - Phd, Clinical Neuroscience - Advanced Therapeutics from University Of Cambridge.

What skills is Michael Whitehead known for?

Michael Whitehead is listed with skills including Communication, Team Leadership, Presentations, Problem Solving, Biochemistry, Management, Competitive Analysis, and Market Research.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.

People with similar names

Check these profiles if this is not the Michael Whitehead you were looking for.

View similar profiles